Demonstrating further market share gains, full-year 2023 sales rose by 20.5%(CER) to CHF 212.0 million. The EMEA region was the driving force with strong growth of 19.8%, exceeding the CHF 100 million…
Medartis reported half-year sales of CHF 103.3 million, representing growth of 20.8% at CER. Internal growth amounted to 16.1%.The EMEA business made the largest contribution to this growth with an…
Distal Radius System 2.5 – Precision you can trust a million times over. We are proud to announce that we have reached a major milestone – we have officially sold over 1.000.000 plates from the APTUS…
The shareholders of the Medartis Holding AG (SIX: MED) today approved all proposals of the Board of Directors with a clear majority of more than 89,7%. After the pandemic years, the Assembly took…
Medartis, a specialized orthopedic company for upper and lower extremity surgery, today announced the full commercial launch of its LapiPrep Lapidus Correction and Preparation System to the U.S.…
Medartis, a specialized orthopaedic company for head and extremity surgery, announced that it has entered into an exclusive global distribution partnership with the Australian-based Field…
Medartis, an orthopaedic company specializing in upper and lower extremity solutions with US headquarters based in Warsaw, IN, today announced a favorable first clinical use of its StealthFix™…
Medartis, a specialized orthopedic company for upper and lower extremity surgery, today announced favorable first clinical uses of its LapiPrep Lapidus Correction and Preparation System.
Basel, Switzerland, March 7, 2022 — Medartis, a Swiss-based orthopedic company for head and extremity surgery, has announced its intent to acquire Nextremity Solutions, Inc.
